Bioactive Compounds
-
N1314 Sweroside -
BA2272 CCF0058981Summary: CCF0058981 (CCF981) is a 3-chlorophenyl analog, a non-covalent inhibitor. - BA2271 Vps34-IN-2Summary: Vps34-IN-2 is a novel, potent and selective inhibitor.
- BA2270 PomotrelvirSummary: Pomotrelvir (PBI-0451) is a selective, orally active 3CL protease inhibitor.
- BA2269 GS-621763Summary: GS-621763 is an orally effective precursor to GS-441524.
- C8565 EGFR-IN-47
- BA2267 IbuzatrelvirSummary: Ibuzatrelvir (PF-07817883), second-generation oral bioavailability, is a SARS-CoV-2 major protease (and) inhibitor with improved metabolic stability.
- C8546 EGFR-IN-59
- BA2266 EnoxaparinSummary: Enoxaparin (PK10169) is a low molecular heparin (LMWH) derivative.
- C8497 KRAS inhibitor-9